Cypherpunk Technologies (NASDAQ:CYPH – Get Free Report) was the recipient of unusually large options trading on Friday. Stock investors bought 4,236 put options on the stock. This is an increase of approximately 104% compared to the typical volume of 2,075 put options.
Analyst Upgrades and Downgrades
CYPH has been the topic of several research reports. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $1.60 price target on shares of Cypherpunk Technologies in a report on Thursday, August 27th. Weiss Ratings upgraded shares of Cypherpunk Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, August 17th. Finally, Wall Street Zen raised shares of Cypherpunk Technologies from a “sell” rating to a “hold” rating in a research note on Saturday, July 4th. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $1.60.
Read Our Latest Stock Analysis on CYPH
Insider Buying and Selling
Hedge Funds Weigh In On Cypherpunk Technologies
Several large investors have recently modified their holdings of CYPH. Millennium Management LLC bought a new stake in shares of Cypherpunk Technologies in the fourth quarter worth $37,000. LPL Financial LLC bought a new position in Cypherpunk Technologies during the 4th quarter worth $38,000. Caitong International Asset Management Co. Ltd bought a new position in Cypherpunk Technologies during the 4th quarter worth $44,000. Sequoia Financial Advisors LLC acquired a new position in Cypherpunk Technologies during the 4th quarter worth about $56,000. Finally, HighTower Advisors LLC acquired a new position in Cypherpunk Technologies during the 4th quarter worth about $59,000. Institutional investors own 30.46% of the company’s stock.
Cypherpunk Technologies Stock Down 3.7%
Shares of CYPH stock traded down $0.09 during mid-day trading on Friday, reaching $2.19. 5,265,259 shares of the stock traded hands, compared to its average volume of 3,954,247. The company has a market cap of $235.46 million, a price-to-earnings ratio of 3.90 and a beta of 0.33. The stock’s fifty day simple moving average is $0.91 and its two-hundred day simple moving average is $0.86. Cypherpunk Technologies has a 1-year low of $0.27 and a 1-year high of $3.70.
Cypherpunk Technologies (NASDAQ:CYPH – Get Free Report) last released its quarterly earnings data on Wednesday, August 12th. The company reported $0.18 earnings per share (EPS) for the quarter.
About Cypherpunk Technologies
Cypherpunk Technologies Inc, previously known as Leap Therapeutics, Inc, is a company developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The company’s research platform centers on modulating the tumor microenvironment to enhance anti-tumor immune responses. Cypherpunk’s proprietary pipeline includes DKN-01, a monoclonal antibody designed to neutralize Dickkopf-1 (DKK1), a protein implicated in tumor growth and immune evasion.
DKN-01 is being evaluated both as a monotherapy and in combination with checkpoint inhibitors such as pembrolizumab across multiple solid tumor indications, including gastroesophageal, pancreatic and other advanced malignancies.
See Also
- Five stocks we like better than Cypherpunk Technologies
- Snowflake’s AI Momentum Is Forcing a Fresh Look at the Stock
- Vertiv’s UIG Deal Targets the Next Big Constraint in AI Data Centers
- Defense Stocks Are Pulling Back as Their Navy Tailwinds Get Stronger
- Survey Reveals: America’s Top Autumn Activities that are Free [2026]
Receive News & Ratings for Cypherpunk Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cypherpunk Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
